DMAC Return on Tangible Equity | DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. (DMAC) Return on Tangible Equity

2026-06-30: Return Tang Equity -97.92%.
2026-03-31: Return Tang Equity -74.31%.
2025-12-31: Return Tang Equity -58.39%.
2025-09-30: Return Tang Equity -61.85%.

Complete source-backed return tang equity history.

Available history: 2017-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-97.92%
2026-03-31	-74.31%
2025-12-31	-58.39%
2025-09-30	-61.85%
2025-06-30	-108.87%
2025-03-31	-79.52%
2024-12-31	-60.03%
2024-09-30	-45.25%
2024-06-30	-37.26%
2024-03-31	-41.55%
2023-12-31	-37.96%
2023-09-30	-32.31%
2023-06-30	-27.72%
2023-03-31	-57.14%
2022-12-31	-42.97%
2022-09-30	-37.55%
2022-06-30	-35.96%
2022-03-31	-33.06%
2021-12-31	-30.87%
2021-09-30	-30.93%
2021-06-30	-70.33%
2021-03-31	-58.28%
2020-12-31	-47.25%
2020-09-30	-35.53%
2020-06-30	-87.18%
2020-03-31	-73.72%
2019-12-31	-139.81%
2019-09-30	-104.44%
2019-06-30	-77.51%
2019-03-31	-59.95%
2018-12-31	-33.68%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-58.39%
2024-12-31	-60.03%
2023-12-31	-37.96%
2022-12-31	-42.97%
2021-12-31	-30.87%
2020-12-31	-47.25%
2019-12-31	-139.81%
2018-12-31	-33.68%
2017-12-31	-533.17%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
PROTHENA CORP PUBLIC LTD CO (PRTA)	Ireland	$0.428B	-11.53
Atea Pharmaceuticals, Inc. (AVIR)	United States	$0.414B	-2.26
ARS Pharmaceuticals, Inc. (SPRY)	United States	$0.414B	-3.70
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63
RELMADA THERAPEUTICS, INC. (RLMD)	United States	$0.406B	-11.92
Opus Genetics, Inc. (IRD)	United States	$0.406B	-3.16
Quoin Pharmaceuticals Ltd. (QNRX)		$0.443B	-17.85
Arcturus Therapeutics Holdings Inc. (ARCT)		$0.402B	-2.05
GALECTIN THERAPEUTICS INC (GALT)	United States	$0.399B	-11.06
Turn Therapeutics Inc. (TTRX)	United States	$0.397B	-25.68